Unbuzzd Wellness Inc., a portfolio company of Quantum BioPharma, has taken significant steps toward potential public offering preparations by appointing MNP LLP as its new auditor. The company, formerly known as Celly Nutrition Corp., completed a formal name change effective May 23, 2025, with no impact on existing shareholder rights.
The auditor appointment follows the resignation of Stern & Lovrics LLP and aligns with the company's previously announced engagement of a New York investment bank for capital raising and public listing advisory services. This strategic move suggests Unbuzzd Wellness is positioning itself for a potential initial public offering in the near future.
The development is part of a broader strategy by Quantum BioPharma to develop and strategically position innovative biotech assets. Quantum BioPharma maintains a 25.71% ownership stake in Unbuzzd Wellness and has negotiated a royalty agreement that could generate substantial long-term revenue.
Under the royalty agreement, Quantum BioPharma will receive 7% of Unbuzzd's sales until total payments reach $250 million, after which the royalty rate will decrease to 3% in perpetuity. The company also retains full rights to develop similar products for pharmaceutical and medical applications.
These strategic maneuvers indicate a carefully planned approach to business expansion and potential market capitalization for Unbuzzd Wellness, with potential implications for investors and the broader beverage and wellness industry.
